Sunday, December 3, 2023

OCULUS GONIO ready ®


 

The OCULUS GONIO ready ® is a microscope attachment developed by Oculus, that enables the surgeon to perform MIGS procedures easily with both hands.



Currently, the surgeon has to hold the gonio-lens with one hand when performing MIGS procedures.




With this device, the surgeon is free to use both hands and have a bimanual approach when performing glaucoma surgeries.

It is possible to use this attachment with a number of microscopes. The list of compatible microscopes is available at the OCULUS GONIO ready ® website.

https://www.oculussurgical.com/gonioready?utm_campaign=GONIO_ready&utm_source=bmc.glaucoma_today&utm_content=GONIO_ready&utm_medium=sticky_banner.website

The device is for single-use only, overcoming the hassle of sterilization of the gonio-lenses and providing excellent optical quality consistently.

The device is small, yet provides impeccable depth of field and a large field of view (180-degrees), thus, improving the peripheral awareness.




Due to small size of the device, it can be used in pediatric patients also.

The device has a patented Flex System, a flexible “swan neck”, which enables surgeons to allow the lens to float atop the cornea, reducing image distortion and offering better access to corneal incisions for any MIGS device.

This system avoids creating any additional pressure against the patient’s eye, ensuring a more comfortable and relaxing patient experience. Additionally, the Flex System is flexible enough to be moved around during MIGS but is sufficiently resistant to movement so as not to be inadvertently displaced, thus offering consistent, repeatable, and stable lens positioning throughout the procedure.

The device is specifically designed to optimize performance with either a f = 175 mm or f = 200 mm microscope objective lens: 

  • 10011226: GONIO ready® 175, for f = 175 mm
  • 10008420: GONIO ready® 200, for f = 200 mm


 

No comments:

Post a Comment

LIGHT-ACTIVATED LIPOSOMES FOR GLAUCOMA

  Biomedical researchers at Binghamton University in the USA, have developed a mechanism for drug-carrying liposomes that can be activated i...